North Thames recruitment to 100,000 genome project exceptionally strong for rare diseases
14 Dec 2016, 9:41 a.m.
The North Thames Genomic Medicine Centre’s (GMC) has recruited 5,200 genomes to the 100,000 Genomes project for rare diseases, making up around 28% of those recruited nationally.
Impact of EU Referendum vote on gene and cell therapy in the UK
4 Oct 2016, 1:58 p.m.
In a new editorial published in Human Gene Therapy, leading researchers call for urgent action to ensure continued access to critical funding and ongoing collaborative opportunities with the broader scientific community in the European Union.
Identification of biomarker which could aid risk stratification in Juvenile Dermatomyositis
16 Sep 2016, 11:12 a.m.
Research led by BRC-funded Professor Lucy Wedderburn has shown that muscle pathology and myositis-specific antibodies (MSA) predict the risk of remaining on treatment in Juvenile Dermatomyositis (JDM). These findings could aid risk stratification.
Research demonstrates clinical and economic benefits of implementing NIPT into NHS care pathway
16 Sep 2016, 11:10 a.m.
The UK National Screening Committee, based on a research programme led by BRC-funded Professor Lynn Chitty, has recommended to the Government that NIPT for Down’s Syndrome be implemented into the NHS maternity care pathway and is currently awaiting minist
Construction underway of Zayed Centre featuring new ‘cleanrooms’ for the production of gene and cell therapy medicinal products
16 Sep 2016, 11:06 a.m.
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be m